cystamine has been researched along with Hypertrophy, Right Ventricular in 1 studies
Hypertrophy, Right Ventricular: Enlargement of the RIGHT VENTRICLE of the heart. This increase in ventricular mass is often attributed to PULMONARY HYPERTENSION and is a contributor to cardiovascular morbidity and mortality.
| Excerpt | Relevance | Reference |
|---|---|---|
| " The hypothesis of the present study was that treatment with the transglutaminase inhibitor, cystamine, would inhibit the development of pulmonary arterial remodeling, pulmonary hypertension, and right ventricular hypertrophy." | 8.02 | Cystamine Treatment Fails to Prevent the Development of Pulmonary Hypertension in Chronic Hypoxic Rats. ( Aalling, M; Andersen, CU; Markvardsen, LK; Mogensen, S; Pinilla, E; Prat-Duran, J; Simonsen, U; Sønderskov, LD; Wandall-Frostholm, C, 2021) |
| " The hypothesis of the present study was that treatment with the transglutaminase inhibitor, cystamine, would inhibit the development of pulmonary arterial remodeling, pulmonary hypertension, and right ventricular hypertrophy." | 4.02 | Cystamine Treatment Fails to Prevent the Development of Pulmonary Hypertension in Chronic Hypoxic Rats. ( Aalling, M; Andersen, CU; Markvardsen, LK; Mogensen, S; Pinilla, E; Prat-Duran, J; Simonsen, U; Sønderskov, LD; Wandall-Frostholm, C, 2021) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Markvardsen, LK | 1 |
| Sønderskov, LD | 1 |
| Wandall-Frostholm, C | 1 |
| Pinilla, E | 1 |
| Prat-Duran, J | 1 |
| Aalling, M | 1 |
| Mogensen, S | 1 |
| Andersen, CU | 1 |
| Simonsen, U | 1 |
1 other study available for cystamine and Hypertrophy, Right Ventricular
| Article | Year |
|---|---|
Cystamine Treatment Fails to Prevent the Development of Pulmonary Hypertension in Chronic Hypoxic Rats.
Topics: Animals; Arterial Pressure; Cystamine; Disease Models, Animal; Enzyme Inhibitors; Female; Hypertensi | 2021 |